“Patient-Level, Visit-by-Visit Data Highlight the Extent of Skin and Itch Improvement in Atopic Dermatitis With Lebrikizumab”. 2023. SKIN The Journal of Cutaneous Medicine 7 (6): s275. https://doi.org/10.25251/skin.7.supp.275.